February 14, 2024 • 4:07 PM EST Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
February 12, 2024 • 9:00 AM EST Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer